ÂÜÀòÂÒÂ×

Ann Laszczyk, PhD, serves as a Clinical Trial Manager at Natera since October 2021, overseeing investigator-initiated studies within the Clinical Development team. With a strong foundation in clinical research from the University of Michigan Medical School, where Ann held postdoctoral fellowships in Nephrology and Psychiatry, extensive expertise in chronic kidney disease and bipolar disorder therapies was cultivated. Additionally, experience as a Research Scientist in Neuroscience at the University of Alabama at Birmingham focused on the Klotho protein and its implications in cognitive decline. Ann is recognized for securing NIH funding, maintaining regulatory compliance, and has a PhD in Cellular & Molecular Biology and Neurobiology as well as a BS in General Biology from Central Michigan University.